Low molecular weight immunopotentiators
- 31 December 1988
- journal article
- review article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 10 (5), 497-510
- https://doi.org/10.1016/0192-0561(88)90066-5
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- In vivo effect of isoprinosine on interleukin-2 production, lymphocyte mitogenesis and NK activity in normal and cyclophosphamide immunosuppressed miceInternational Journal of Immunopharmacology, 1986
- Clinical and immunological effects of imuthiolR durign chronic infections in manInternational Journal of Immunopharmacology, 1985
- Effect of imuthiol administration to normal or immunodeficient mice on IL1 and IL2 production and immune responses regulated by these mediatorsInternational Journal of Immunopharmacology, 1985
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- Increased sensitivity of IL2-dependent cultured T cells and enhancement of in vitro IL2 production by human lymphocytes treated with bestatinInternational Journal of Immunopharmacology, 1984
- Tuftsin: A hormone-like tetrapeptide with antimicrobial and antitumor activitiesLife Sciences, 1981
- A Randomized Trial of Levamisole versus Placebo as Adjuvant Therapy in Malignant MelanomaNew England Journal of Medicine, 1980
- Reduction of acute toxicity of cyclophosphamide and X-rays by the new immunomodulating compound BM 12.531Cellular and Molecular Life Sciences, 1979
- Dl-2-oxo-3-(2-mercaptoethyl)-5-phenylimidazolidine. A sulfhydryl metabolite of levamisole that interacts with microtubulesChemico-Biological Interactions, 1978
- Total synthesis and adjuvant activity of bacterial peptidoglycan derivativesBiochemical and Biophysical Research Communications, 1975